AU3063800A - Drugs for treatment of psychiatric and brain disorders - Google Patents

Drugs for treatment of psychiatric and brain disorders

Info

Publication number
AU3063800A
AU3063800A AU30638/00A AU3063800A AU3063800A AU 3063800 A AU3063800 A AU 3063800A AU 30638/00 A AU30638/00 A AU 30638/00A AU 3063800 A AU3063800 A AU 3063800A AU 3063800 A AU3063800 A AU 3063800A
Authority
AU
Australia
Prior art keywords
psychiatric
drugs
treatment
brain disorders
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30638/00A
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laxdale Ltd
Original Assignee
Laxdale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laxdale Ltd filed Critical Laxdale Ltd
Publication of AU3063800A publication Critical patent/AU3063800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU30638/00A 1999-01-27 2000-01-20 Drugs for treatment of psychiatric and brain disorders Abandoned AU3063800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9901808 1999-01-27
GBGB9901808.7A GB9901808D0 (en) 1999-01-27 1999-01-27 Drugs for treatment of psychiatric and brain disorders
PCT/GB2000/000137 WO2000044360A2 (en) 1999-01-27 2000-01-20 Drugs for treatment of psychiatric and brain disorders

Publications (1)

Publication Number Publication Date
AU3063800A true AU3063800A (en) 2000-08-18

Family

ID=10846602

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30638/00A Abandoned AU3063800A (en) 1999-01-27 2000-01-20 Drugs for treatment of psychiatric and brain disorders

Country Status (3)

Country Link
AU (1) AU3063800A (en)
GB (1) GB9901808D0 (en)
WO (1) WO2000044360A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
US20060217303A1 (en) * 2005-03-25 2006-09-28 Wisconsin Alumni Research Foundation Compounds and Methods for Treating Seizure Disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
GB8714772D0 (en) * 1987-06-24 1987-07-29 Efamol Ltd Essential fatty acid compositions
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
US5658767A (en) * 1991-01-24 1997-08-19 Martek Corporation Arachidonic acid and methods for the production and use thereof
JPH06237734A (en) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd Food composition for hypofunctional disease
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
JPH08143454A (en) * 1994-11-17 1996-06-04 Kanagawa Kagaku Kenkyusho:Kk Nerve growth factor production enhancer
GB9506837D0 (en) * 1995-04-03 1995-05-24 Scotia Holdings Plc Triglycerides
EP1886679A3 (en) * 1995-06-07 2008-05-28 Martek Biosciences Corporation Methods for controlling highly unsaturated fatty acid content in various tissues
GB9515160D0 (en) * 1995-07-24 1995-09-20 Scotia Holdings Plc Diagnostic test
WO1997039759A2 (en) * 1996-04-24 1997-10-30 Brigham And Women's Hospital Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
PT956013E (en) * 1996-10-11 2003-08-29 Scarista Ltd PHARMACEUTICAL PREPARATION COMPOSING Eicosapentaenoic acid and / or stearidonic acid
WO1998048788A1 (en) * 1997-04-29 1998-11-05 Scotia Holdings Plc Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants

Also Published As

Publication number Publication date
WO2000044360A2 (en) 2000-08-03
WO2000044360A3 (en) 2000-11-30
GB9901808D0 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
AU6462500A (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
AU2001236904A1 (en) Deep brain stimulation system for the treatment of parkinson's disease or other disorders
AU1474001A (en) Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
AU2604301A (en) Tnf inhibitors for the treatment of neurological, retinal and muscular disorders
HUP0400914A3 (en) Methods of treatment of mitochondrial disorders
AU1520699A (en) Methods for treatment of disorders of cardiac contractility
AU2436397A (en) Method of treating movement disorders by brain stimulation and drug infusion
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU6910600A (en) Methods for the treatment of mental disorders
IL141263A0 (en) Methods for treatment of neurological disorders
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
AU3977700A (en) Method of treating neurological disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU2058697A (en) Treatment of sleep disorders
AU3784999A (en) Methods for treatment of pain
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU1356201A (en) Treatment of hyperproliferative disorders
AU3896900A (en) Treatment of pain
GB9926968D0 (en) Treatment of neurological disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
AU5912900A (en) Quinuclidine derivatives for treatment of neurological disorders
AU7106300A (en) Treatment of skin disorders
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase